Transcriptomic Profiling Services for Bladder Cancer
Transcriptomic profiling is a powerful tool that allows researchers to study the expression levels of all genes in a cell or tissue at a given time. Alfa Cytology provides transcriptomic services for bladder cancer research and assists our customers in achieving their goals.
Transcriptomic in Bladder cancer
Bladder cancer is a prevalent and highly morbid disease worldwide, necessitating the development of advanced research tools and services for its diagnosis. Transcriptomics, which involves the analysis of gene expression patterns, holds significant promise in understanding the molecular mechanisms underlying bladder cancer and identifying potential biomarkers.
Here are some key findings from transcriptomic studies in bladder cancer:
- Pathways and Signaling Networks
- Drug Discovery and Therapeutic Targets
Fig.1 Bladder tumor transcriptome reveals insights into luminal and basal subtypes. (Luo Y. X., et al. 2022)
Our Services
Alfa Cytology, a leading preclinical CRO company, offers comprehensive transcriptomics services specifically tailored to bladder cancer research. Get qualitative and quantitative information about the activity of your genes with custom gene expression services.
Whole Transcriptome Analysis
We are able to help our clients characterize all RNA transcripts, including small RNAs, circRNAs, lncRNAs, and mRNAs, in bladder cancer-related samples, providing a comprehensive understanding of gene expression patterns.
Target Gene Expression Analysis
We provide quantitative analysis services of mRNA expression of specific target genes (e.g., in different genotypes of bladder cancer, before and during drug therapy, or after administration of candidate compounds in the preclinical phase of drug development.
Non-Coding RNA Analysis
We analyze non-coding RNAs such as micro RNAs (miRNAs) and long non-coding RNAs (lncRNAs) in bladder cancer samples to help you gain insight into their role in bladder cancer pathogenesis.
Transcriptome Profiling Array
Our transcriptome microarray analysis service can be tailored to your specific project research. Offering end-to-end transcriptome microarray analysis services, we provide you with more flexibility and less costly transcriptome analysis.
Our services will help you achieve the goals including but not limited to the follows:
- Biomarkers identification for bladder cancer
- Elucidation of disease mechanisms for bladder cancer
- Molecular characterization of bladder cancer
- Identification of bladder cancer subgroups
- Study of drug modes of action for bladder cancer
Project Workflow
Contact Us
If you are conducting bladder cancer research and seeking advanced transcriptomics services, Alfa Cytology is here to support you. Our experienced team of scientists and state-of-the-art technologies can provide valuable insights into the molecular mechanisms of bladder cancer, identification of potential biomarkers, and development of personalized therapeutic approaches. Contact us today to discuss your project requirements.
References
- Biton A., Bernard-Pierrot I., and et al. Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes. Cell Rep. 2014, 9(4): 1235-45.
- Giulietti M., Occhipinti G., and et al. Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data. Front Oncol. 2018, 12, 8: 450.
For research use only. Not intended for any clinical use.
Related Services
